🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jonathan Zorea

ORCID: 0000-0002-8602-8869
Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer”.

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.22.457244
N/A
0DataRank · unranked
2 citations

Jonathan Zorea, Sankar Jagadeeshan, Avital Beeri Shnerb, Jebrane Bouaoud, Lucas Michon +24 more

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003917
N/A
0DataRank · unranked
70 citations

Jonathan Zorea, Sankar Jagadeeshan, Avital Beeri Shnerb, Sooraj Mathukkada, Jebrane Bouaoud +27 more

Activation of the EGFR / PI3K / AKT pathway limits the efficacy of trametinib treatment in head and neck cancer

Molecular Oncology(2023)10.1002/1878-0261.13500
N/A
0DataRank · unranked
34 citations

Avital Beeri Shnerb, Divyasree Marripati, Sankar Jagadeeshan, Raghda Abu Shareb, Cristina Conde‐López +13 more

Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-2586
N/A
0DataRank · unranked
24 citations

Manu Prasad, Mai Badarni, Talal Ben Lulu, Vijayasteltar Belsamma Liju, Sooraj Mathukkada +20 more